Gland Pharma Limited announced today that it has received United States Food and Drug Administration (USFDA) approval for Latanoprost Ophthalmic Solution, 0.005 per...
Target: ₹1,970CMP: ₹1,832.45Gland Pharma delivered better-than-expected operational performance for the quarter. Despite increased EBITDA loss at Cenexi y-o-y/q-o-q and a lower share of...